天津市医药采购中心日前发布通知明确，此次集中带量采购方式为带量联动、双向选择，即依据采购主体使用需求，参照市场总体价格水平、综合质量等因素，联动全国各省（自治区、直辖市）带量采购价格，通过购销双方相互选择，确定中选产品，实行带量联动采购。分层设定报价上限据悉，京津冀“3+N”联盟中药配方颗粒带量联动采购由天津医保局牵头，北京、天津、河北为主。“N”的部分，在2024年集采时已覆盖江苏、浙江、河南、...
Source Link天津市医药采购中心日前发布通知明确，此次集中带量采购方式为带量联动、双向选择，即依据采购主体使用需求，参照市场总体价格水平、综合质量等因素，联动全国各省（自治区、直辖市）带量采购价格，通过购销双方相互选择，确定中选产品，实行带量联动采购。分层设定报价上限据悉，京津冀“3+N”联盟中药配方颗粒带量联动采购由天津医保局牵头，北京、天津、河北为主。“N”的部分，在2024年集采时已覆盖江苏、浙江、河南、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.